184 related articles for article (PubMed ID: 22921518)
21. Poly (lactide-co-glycolide)-polymethacrylate nanoparticles for intramuscular delivery of plasmid encoding interleukin-10 to prevent autoimmune diabetes in mice.
Basarkar A; Singh J
Pharm Res; 2009 Jan; 26(1):72-81. PubMed ID: 18779928
[TBL] [Abstract][Full Text] [Related]
22. PLGA nanoparticle-mediated delivery of tumor antigenic peptides elicits effective immune responses.
Ma W; Chen M; Kaushal S; McElroy M; Zhang Y; Ozkan C; Bouvet M; Kruse C; Grotjahn D; Ichim T; Minev B
Int J Nanomedicine; 2012; 7():1475-87. PubMed ID: 22619507
[TBL] [Abstract][Full Text] [Related]
23. Combining R-DOTAP and a particulate antigen delivery platform to trigger dendritic cell activation: Formulation development and in-vitro interaction studies.
Riehl M; Harms M; Hanefeld A; Baleeiro RB; Walden P; Mäder K
Int J Pharm; 2017 Oct; 532(1):37-46. PubMed ID: 28866132
[TBL] [Abstract][Full Text] [Related]
24. Genetic immunization using nanoparticles engineered from microemulsion precursors.
Cui Z; Mumper RJ
Pharm Res; 2002 Jul; 19(7):939-46. PubMed ID: 12180545
[TBL] [Abstract][Full Text] [Related]
25. Polymer nanoparticles for cross-presentation of exogenous antigens and enhanced cytotoxic T-lymphocyte immune response.
Song C; Noh YW; Lim YT
Int J Nanomedicine; 2016; 11():3753-64. PubMed ID: 27540289
[TBL] [Abstract][Full Text] [Related]
26. Nanomaterial-dependent immunoregulation of dendritic cells and its effects on biological activities of contraceptive nanovaccines.
Xu P; Tang S; Jiang L; Yang L; Zhang D; Feng S; Zhao T; Dong Y; He W; Wang R; Zhang J; Liang Z
J Control Release; 2016 Mar; 225():252-68. PubMed ID: 26826303
[TBL] [Abstract][Full Text] [Related]
27. Composition and surface charge of DNA-loaded microparticles determine maturation and cytokine secretion in human dendritic cells.
Jilek S; Ulrich M; Merkle HP; Walter E
Pharm Res; 2004 Jul; 21(7):1240-7. PubMed ID: 15290866
[TBL] [Abstract][Full Text] [Related]
28. Rational Design of PLGA Nanoparticle Vaccine Delivery Systems To Improve Immune Responses.
Gu P; Wusiman A; Zhang Y; Liu Z; Bo R; Hu Y; Liu J; Wang D
Mol Pharm; 2019 Dec; 16(12):5000-5012. PubMed ID: 31621331
[TBL] [Abstract][Full Text] [Related]
29. Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen.
Slütter B; Bal S; Keijzer C; Mallants R; Hagenaars N; Que I; Kaijzel E; van Eden W; Augustijns P; Löwik C; Bouwstra J; Broere F; Jiskoot W
Vaccine; 2010 Aug; 28(38):6282-91. PubMed ID: 20638455
[TBL] [Abstract][Full Text] [Related]
30. Small molecule delivery to solid tumors with chitosan-coated PLGA particles: A lesson learned from comparative imaging.
Park J; Pei Y; Hyun H; Castanares MA; Collins DS; Yeo Y
J Control Release; 2017 Dec; 268():407-415. PubMed ID: 29111150
[TBL] [Abstract][Full Text] [Related]
31. Surface modification of poly(D,L-lactic-co-glycolic acid) nanoparticles with protamine enhanced cross-presentation of encapsulated ovalbumin by bone marrow-derived dendritic cells.
Han R; Zhu J; Yang X; Xu H
J Biomed Mater Res A; 2011 Jan; 96(1):142-9. PubMed ID: 21105162
[TBL] [Abstract][Full Text] [Related]
32. Induction of mucosal and systemic immune response by single-dose oral immunization with biodegradable microparticles containing DNA encoding HBsAg.
He XW; Wang F; Jiang L; Li J; Liu SK; Xiao ZY; Jin XQ; Zhang YN; He Y; Li K; Guo YJ; Sun SH
J Gen Virol; 2005 Mar; 86(Pt 3):601-610. PubMed ID: 15722520
[TBL] [Abstract][Full Text] [Related]
33. Enhanced immune response after subcutaneous and oral immunization with biodegradable PLGA microspheres.
Igartua M; Hernández RM; Esquisabel A; Gascón AR; Calvo MB; Pedraz JL
J Control Release; 1998 Dec; 56(1-3):63-73. PubMed ID: 9801430
[TBL] [Abstract][Full Text] [Related]
34. Coated and Hollow Microneedle-Mediated Intradermal Immunization in Mice with Diphtheria Toxoid Loaded Mesoporous Silica Nanoparticles.
Du G; Woythe L; van der Maaden K; Leone M; Romeijn S; Kros A; Kersten G; Jiskoot W; Bouwstra JA
Pharm Res; 2018 Aug; 35(10):189. PubMed ID: 30105542
[TBL] [Abstract][Full Text] [Related]
35. Non-invasive delivery of nanoparticles to hair follicles: a perspective for transcutaneous immunization.
Mittal A; Raber AS; Schaefer UF; Weissmann S; Ebensen T; Schulze K; Guzmán CA; Lehr CM; Hansen S
Vaccine; 2013 Jul; 31(34):3442-51. PubMed ID: 23290836
[TBL] [Abstract][Full Text] [Related]
36. Rationalizing the use of functionalized poly-lactic-co-glycolic acid nanoparticles for dendritic cell-based targeted anticancer therapy.
Kokate RA; Chaudhary P; Sun X; Thamake SI; Maji S; Chib R; Vishwanatha JK; Jones HP
Nanomedicine (Lond); 2016; 11(5):479-94. PubMed ID: 26892440
[TBL] [Abstract][Full Text] [Related]
37. Composition of PLGA and PEI/DNA nanoparticles improves ultrasound-mediated gene delivery in solid tumors in vivo.
Chumakova OV; Liopo AV; Andreev VG; Cicenaite I; Evers BM; Chakrabarty S; Pappas TC; Esenaliev RO
Cancer Lett; 2008 Mar; 261(2):215-25. PubMed ID: 18164806
[TBL] [Abstract][Full Text] [Related]
38. Ebola Vaccination Using a DNA Vaccine Coated on PLGA-PLL/γPGA Nanoparticles Administered Using a Microneedle Patch.
Yang HW; Ye L; Guo XD; Yang C; Compans RW; Prausnitz MR
Adv Healthc Mater; 2017 Jan; 6(1):. PubMed ID: 28075069
[TBL] [Abstract][Full Text] [Related]
39. Modified poly(lactic-co-glycolic acid) nanoparticles for enhanced cellular uptake and gene editing in the lung.
Fields RJ; Quijano E; McNeer NA; Caputo C; Bahal R; Anandalingam K; Egan ME; Glazer PM; Saltzman WM
Adv Healthc Mater; 2015 Feb; 4(3):361-6. PubMed ID: 25156908
[TBL] [Abstract][Full Text] [Related]
40. Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration.
Zhang X; Sun M; Zheng A; Cao D; Bi Y; Sun J
Eur J Pharm Sci; 2012 Apr; 45(5):632-8. PubMed ID: 22248882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
